Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Imatinib and Vinorelbine
Sponsor: Novartis Pharmaceuticals